ObjectivesOne stage functional jaw reconstruction is defined as the resection and reconstruction of segmental defects in conjunction with the placement of dental implants in an ideal prosthetic position and loaded with a provisional restoration, during one surgical procedure. The aim of the study is to describe clinical outcomes of patients who underwent one stage functional jaw reconstruction.MethodsPatients who underwent one‐stage functional jaw reconstruction, from January 2013 to March 2016 were recalled in 2022 and 2023. Planning and execution for the reconstruction utilized either analogue or digital techniques. Outcome parameters recorded were treatment‐related outcomes at patient level, implant‐related outcomes and patient‐reported outcome measures.ResultsEighteen patients underwent one‐stage jaw reconstruction with a total of 57 implants. Four patients had maxillary and 14 had mandibular reconstructions. Ten patients underwent postoperative radiotherapy. Ten patients were planned using analogue and eight by digital planning. Three patients had partial flap necrosis, three patients had plate fractures, implant loss was seen in one patient and four patients died during the period. A functional prosthesis was provided in 16 out of the 18 patients.ConclusionOne‐stage functional jaw reconstruction is a predictable method for providing rehabilitation with successful outcomes at 7–11 years. However, caution should be exercised when the treatment modality is carried out in patients with malignant pathologies who have undergone radiotherapy.

中文翻译：

---

良性和恶性疾病患者的一期修复驱动颌骨重建：一项 7 至 11 年的队列研究


目的一期功能性颌骨重建定义为在一次外科手术中，将节段性缺损切除和重建，同时将种植牙放置在理想的修复体位置并加载临时修复体。该研究的目的是描述接受一期功能性颌骨重建的患者的临床结果。方法对 2013 年 1 月至 2016 年 3 月接受一期功能性颌骨重建的患者进行 2022 年和 2023 年回顾。重建的规划和执行使用了模拟或数字技术。记录的结局参数是患者层面的治疗相关结局、种植体相关结局和患者报告的结局指标。结果18 例患者接受了一期颌骨重建，共 57 例植入物。4 例患者有上颌骨重建，14 例有下颌骨重建。10 例患者接受术后放疗。10 名患者使用模拟计划，8 名患者通过数字计划计划。3 例患者出现部分皮瓣坏死，3 例患者出现钢板骨折，1 例患者出现植入物缺失，4 例患者在此期间死亡。18 例患者中有 16 例提供了功能性假体。结论一期功能性颌骨重建是一种可预测的方法，可在 7-11 岁时提供成功治疗的康复。然而，当对接受放疗的恶性病变患者进行治疗方式时，应谨慎行事。